about
Comparability of quality-of-care indicators for emergency coronary angioplasty in patients with acute myocardial infarction regardless of on-site cardiac surgery (report from the National Registry of Myocardial Infarction)Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4)Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction.Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National InstitTrends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.Hospital-level performance improvement: beta-blocker use after acute myocardial infarction.Second opinion in breast pathology: policy, practice and perception.Demographic and practice characteristics of pathologists who enjoy breast tissue interpretation.Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction.How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.Use of Digital Whole Slide Imaging in Dermatopathology.Identifying and processing the gap between perceived and actual agreement in breast pathology interpretationImpact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarctionRacial differences in reperfusion therapy use in patients hospitalized with myocardial infarction: a regional phenomenon.The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions.Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.The diagnostic challenge of low-grade ductal carcinoma in situ.Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens.Characteristics associated with requests by pathologists for second opinions on breast biopsies.Region of interest identification and diagnostic agreement in breast pathology.The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making.The self-reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected statesDiagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?Medical malpractice concerns and defensive medicine: a nationwide survey of breast pathologists.Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.Measles in pregnancy: a descriptive study of 58 cases.Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.Hospital performance with myocardial reperfusion therapy: are hospitals capable of meeting established guidelines?Impact of pregnancy on women with cystic fibrosis.ST-segment depression on the initial electrocardiogram in acute myocardial infarction-prognostic significance and its effect on short-term mortality: A report from the National Registry of Myocardial Infarction (NRMI-2, 3, 4).Association of initial thrombolysis in myocardial infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a National Registry of Myocardial InfarctionApplication of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.A survey of hospital infection control policies and employee measles cases during Los Angeles County's measles epidemic, 1987 to 1989.Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006.Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators.Predictors of door-to-balloon delay in primary angioplasty.
P50
Q28168766-C2DC5D9C-131E-45CD-8BE9-35B8CC3F68CAQ28188255-6DEBFF51-4F0B-4D5F-9341-1515FEFE6684Q28192224-EA24324C-A924-429B-96AD-35DD6EBE128CQ33296962-2F7A04C7-EEA9-47F5-9891-DFF0B01E37B7Q34198120-EAC6E041-04D7-4430-9CF7-7EBA214573F0Q34437397-9FD9CF8A-8C06-47DE-BF08-9CB26D4D545AQ35786868-B1011A49-87C9-44FC-BFD3-9402EE339C38Q35905599-67A12D8D-A85C-4645-A32C-8CEDB034A0DFQ35910935-6E5E573F-F38D-40C4-8481-65775AB9E356Q36052044-B4DFBE41-E6E9-494B-A665-429EF08B9263Q36479737-AA1490F3-341A-4C2A-8338-622B67BD1083Q36678289-505FFBB8-E8EA-405C-AF58-1D72FD53E182Q37047920-76256D94-2040-44E0-8A05-956717ECE5BBQ37273987-22718B09-4C9F-46EA-A66E-A01C20A64558Q37465146-91FC7742-872E-4644-9BFA-E5C887007E03Q37614077-718A6506-F344-4D6D-BDF7-577A334D5E60Q38599840-E30C8B0B-7875-4F5D-9750-A1DF96B69808Q38768759-6428184F-1F04-4700-B02F-882CBCEC3D54Q38801937-4D647215-05BA-4AA0-9BE8-5CE4785C314BQ38808016-4DDB1A6A-0717-4489-BABF-001F5B66DB04Q38838934-71945233-7329-458B-9840-F697D74EF7D9Q39870741-7F66CABE-CF27-4247-9EF0-2CE1FE477E1EQ39927591-08061F9F-E5C0-4723-8C74-2ABE8CF622EEQ40443806-6E47BA61-A7E5-4A13-B45F-8841FE27B8A4Q41120602-45F85A9A-C279-4BEC-B6A8-2F434225F5B7Q42407425-64FC1CFE-57C1-4E03-AA93-5841ED85D893Q42643923-CA40EAEC-9FC7-4795-A668-90C216A8F96FQ43256616-254923F1-E811-462A-AF20-01CE42635E47Q43926741-E7CBD9C6-947D-4776-A05D-120005AD9EC0Q43943203-1DBBAF06-7FD4-4F79-9A80-3BA1F64A3692Q44352059-DEE07AF0-DFAD-49C3-95CA-7C008040111EQ44360059-F6C77C1F-AE9F-4009-9C5F-28C0A87BAA07Q44487468-A3D5D29E-2345-4069-9143-5659D02E7E81Q44582473-8B8D423F-BBB8-43E5-B94C-66EC2C138692Q44877566-EBFBF569-E948-4FCB-BC5C-F80B6BD1EA4CQ45182242-CDA6D7DE-75F5-46AB-8A91-FAE158A7192DQ45999230-53F6CEC5-0974-4A83-8742-4E44C6FEF1E1Q46199164-1733346C-61F0-4EDB-8F9F-82D5AD92EF62Q46210694-14C2ADC6-0659-41A8-BD44-7EFD4B9CC733Q46330057-B6FEBA5E-CEFB-464F-A285-23C0E3D7DEC2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul D. Frederick
@ast
Paul D. Frederick
@en
Paul D. Frederick
@es
Paul D. Frederick
@nl
Paul D. Frederick
@sl
type
label
Paul D. Frederick
@ast
Paul D. Frederick
@en
Paul D. Frederick
@es
Paul D. Frederick
@nl
Paul D. Frederick
@sl
altLabel
Paul D. Frederick
@en
prefLabel
Paul D. Frederick
@ast
Paul D. Frederick
@en
Paul D. Frederick
@es
Paul D. Frederick
@nl
Paul D. Frederick
@sl
P106
P1153
56282612200
P21
P31
P496
0000-0002-7936-5488